Teaming up synthetic chemistry and histochemistry for activity screening in galectin-directed inhibitor design.

A hallmark of endogenous lectins is their ability to select a few distinct glycoconjugates as counterreceptors for functional pairing from the natural abundance of cellular glycoproteins and glycolipids. As a consequence, assays to assess inhibition of lectin binding should necessarily come as close...

Descripción completa

Detalles Bibliográficos
Publicado en:Histochemistry & Cell Biology Vol. 147; no. 2; pp. 285 - 302
Autores principales: Roy, René, Cao, Yihong, Kaltner, Herbert, Kottari, Naresh, Shiao, Tze, Belkhadem, Karima, André, Sabine, Manning, Joachim, Murphy, Paul, Gabius, Hans-Joachim
Formato: Journal Article
Publicado: Springer Nature Feb2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=121186055&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 121186055
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09486143
        NQI
      jtl: Histochemistry & Cell Biology
      issn: 09486143
      maglogo: N
    pubinfo:
      dt: Feb2017
      vid: 147
      iid: 2
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        121186055
        144013180
        10.1007/s00418-016-1525-5
        121186055
      ppf: 285
      ppct: 17
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Teaming up synthetic chemistry and histochemistry for activity screening in galectin-directed inhibitor design.
      aug:
        au:
          Roy, René
          Cao, Yihong
          Kaltner, Herbert
          Kottari, Naresh
          Shiao, Tze
          Belkhadem, Karima
          André, Sabine
          Manning, Joachim
          Murphy, Paul
          Gabius, Hans-Joachim
        affil: Pharmaqam and Nanoqam, Department of Chemistry , University du Québec à Montréal , P.O. Box 8888, Succ. Centre-Ville Montreal H3C 3P8 Canada
      sug:
      ab: A hallmark of endogenous lectins is their ability to select a few distinct glycoconjugates as counterreceptors for functional pairing from the natural abundance of cellular glycoproteins and glycolipids. As a consequence, assays to assess inhibition of lectin binding should necessarily come as close as possible to the physiological situation, to characterize an impact of a synthetic compound on biorelevant binding with pharmaceutical perspective. We here introduce in a proof-of-principle manner work with sections of paraffin-embedded tissue (jejunum, epididymis) and labeled adhesion/growth-regulatory galectins, harboring one (galectin-1 and galectin-3) or two (galectin-8) types of lectin domain. Six pairs of synthetic lactosides from tailoring of the headgroup (3′- O-sulfation) and the aglycone (β-methyl to aromatic S- and O-linked extensions) as well as three bi- to tetravalent glycoclusters were used as test compounds. Varying extents of reduction in staining intensity by synthetic compounds relative to unsubstituted/free lactose proved the applicability and sensitivity of the method. Flanking cytofluorimetric assays on lectin binding to native cells gave similar grading, excluding a major impact of tissue fixation. The experiments revealed cell/tissue binding of galectin-8 preferentially via one domain, depending on the cell type so that the effect of an inhibitor in a certain context cannot be extrapolated to other cells/tissues. Moreover, the work with the other galectins attests that this assay enables comprehensive analysis of the galectin network in serial tissue sections to determine overlaps and regional differences in inhibitory profiles.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N